[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ZhuhuiRiu Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1927250035500101632.png) Jasper-Riu [@ZhuhuiRiu](/creator/twitter/ZhuhuiRiu) on x XXX followers
Created: 2025-07-17 01:50:23 UTC

X. Moderna ( $MRNA ) ★★★★
mRNA technology trailblazer.

Key Strengths:
• Proprietary mRNA platform (COVID/flu combo vaccine in trials)
• Diversified pipeline (cancer vaccine mRNA-4157 Phase 3; rare disease therapies)
• $9.5B cash reserves (2024)
• Merck collaboration advancing oncology vaccines

Growth Potential:
• Targeting XX approved products by 2027
• Post-COVID revenue decline ($1.5-2.5B 2025E) poses near-term risk

![](https://pbs.twimg.com/media/GwBgrdHXgAAhkNM.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945662331016355843/c:line.svg)

**Related Topics**
[$1525b](/topic/$1525b)
[approved](/topic/approved)
[$95b](/topic/$95b)
[combo](/topic/combo)
[stocks technology](/topic/stocks-technology)
[$mrna](/topic/$mrna)
[stocks healthcare](/topic/stocks-healthcare)
[$mrk](/topic/$mrk)

[Post Link](https://x.com/ZhuhuiRiu/status/1945662331016355843)